OOIR: Observatory of International Research

Papers

(The H4-Index of Expert Review of Molecular Diagnostics is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer	104
What makes a « good » companion diagnostic in thoracic oncology?	82
Molecular point-of-care testing in the community pharmacy setting: current status and future prospects	69
Cancer cell-derived extracellular vesicles activate hepatic stellate cells in colorectal cancer	55
Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis	48
Polygenic and Network-based studies in risk identification and demystification of cancer	41
Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features	38
Recent updates in the development of molecular assays for the rapid identification and susceptibility testing of MRSA	35
Mild behavioral impairment and neurodegeneration: time for a biomarker-based assessment	35
Cost analyses for malaria molecular diagnosis for research planners in India and beyond	33
Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell competence	32
Evolution and future of cervical cancer screening: from cytology to primary HPV testing and the impact of vaccination	32
Retrospective analysis of the risk factors associated with failure in obtaining effective noninvasive prenatal test results and pregnancy outcomes: a case-control study	32
Nuclease activity: an exploitable biomarker in bacterial infections	31
Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer	31
Unlocking the power of biomarkers: transforming the diagnosis of acute respiratory distress syndrome	30
Functional proteomic analysis, a missing piece for understanding clonal evolution and cooperation in the tissue microecology	28
RAD51 as a functional biomarker for homologous recombination deficiency in cancer: a promising addition to the HRD toolbox?	27
Diagnostic approach to leptomeningeal involvement in diffuse large B-cell lymphoma	25
A novel anoikis-related signature predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma	25
Diagnosing thrombophilia: the case for genetic or functional testing?	24
The MALAT1-breast cancer interplay: insights and implications	23
Clinical application of noninvasive prenatal testing in twin pregnancies: a single-center experience	22
Genetic risk and gastric cancer: polygenic risk scores in population-based case-control study	22